Ensoma

Series-B+
ensoma.com Biotech & Healthcare Boston, United States 51-100
Total Funding $50M
Latest Round $50M Series-B+
Last Announced May 16, 2023
Investors 12 Backers
Decision Makers 6 Verified

About Ensoma

Develops a genomic medicine platform for in vivo engineering of hematopoietic stem cells.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Boston, United States
Team Size 51-100
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website ensoma.com
Domain Registered Date May 11, 2003

Social & Network Presence

X / Twitter Profile @EnsomaBio (356 followers) Created on Jun 2020
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $50,000,000 · Series-B+

    fundraisingfox.com

  2. Capital Raise

    Series-B+ announced

    fundraisingfox.com

  3. Milestone

    X account created (@EnsomaBio)

    356 followers

  4. Milestone

    Website domain registered

    ensoma.com

Investors & Backers

12
Bill & Melinda Gates Foundation
Bioluminescence Ventures
Cormorant Asset Management
Delos Capital
F-Prime Capital
Gilead Sciences
Kite Pharma
Mirae Asset Financial Group
RTW Investments
Solasta Ventures
SymBiosis
Viking Global Investors

Funding History

2 Rounds
Series-B+ · May 16, 2023
Series-B+ · Jan 10, 2023

Founders & Leadership

5

Andre Lieber

Founder

Work email & phone locked Unlock →

Emile F. Nuwaysir

CEO

Work email & phone locked Unlock →

Hans Peter Kiem

Founder

Work email & phone locked Unlock →

Jon Garen

Chief Corporate Development and Business Officer

Work email & phone locked Unlock →

Min Wang

Chief Operating Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts